Belluscura

BELLHealthcare
0.6750GBX
0.00%
Market Cap
2.71M
Volume
100k
4% of avg
P/E Ratio
EPS (TTM)
0
Beta
0.63
Day Range
0.0000p - 0.0000p
52 Week Range
0.0000p0.6750p18.0000p
0.6750p

Upcoming Events

Q3 2025
Full commercial launch of the DISCOV-R product
High Impact Event
BELL
NEUTRAL

Belluscura Initiates Strategic Review to Address Funding Needs

The medical device company is launching a strategic review to address its funding needs, as it faces product sourcing challenges and seeks to strengthen its capital position.

BELL
GOOD

Belluscura Reports Strong Q1 Sales, Launches New Portable Oxygen Concentrator

The medical device developer reports a substantial increase in Q1 sales and the launch of a new portable oxygen concentrator, despite some tariff-related challenges.

BELL
NEUTRAL

Belluscura Announces Director Shareholding Change

The healthcare company has announced a change in director shareholding.

BELL
NEUTRAL

Belluscura Announces Change in Shareholding

The healthcare company has announced a change in its shareholding structure.

BELL
NEUTRAL

Belluscura Announces Change in Major Shareholding

The medical device company reports a change in major shareholding, with no significant implications.

BELL
NEUTRAL

Belluscura Announces Change in Major Shareholding

The medical device company has announced a change in major shareholding, with Dowgate Group Limited reducing its stake in the business.

BELL
NEUTRAL

Belluscura Announces Director Dealing

The medical device company has announced a change in major shareholding, with a director reducing their stake.

BELL
NEUTRAL

Belluscura Announces Change in Major Shareholding

The medical device company has announced a change in major shareholding, with Cantor Fitzgerald Europe reducing its stake in the firm.

BELL
NEUTRAL

Belluscura Announces Change in Major Shareholding

The medical device company has announced a change in major shareholding, with Dowgate Group Limited increasing its stake in the business.

BELL
NEUTRAL

Belluscura Director Increases Stake

The healthcare company has announced a director has increased their stake in the business.